Differences in the Pathogenicity of the p.H723R Mutation of the Common Deafness-Associated SLC26A4 Gene in Humans and Mice

Ying-Chang Lu; Chen-Chi Wu; Ting-Hua Yang; Yin-Hung Lin; I-Shing Yu; Shu-Wha Lin; Qing Chang; Xi Lin; Jau-Min Wong; Chuan-Jen Hsu

doi:10.1371/journal.pone.0064906

Abstract

Mutations in the SLC26A4 gene are a common cause of human hereditary hearing impairment worldwide. Previous studies have demonstrated that different SLC26A4 mutations have different pathogenetic mechanisms. By using a genotype-driven approach, we established a knock-in mouse model (i.e., Slc26a4^{tm2Dontuh/tm2Dontuh} mice) homozygous for the common p.H723R mutation in the East Asian population. To verify the pathogenicity of the p.H723R allele in mice, we further generated mice with compound heterozygous mutations (i.e., Slc26a4^{tm1Dontuh/tm2Dontuh}) by intercrossing Slc26a4^+/tm2Dontuh mice with Slc26a4^{tm1Dontuh/tm1Dontuh} mice, which segregated the c.919-2A>G mutation with an abolished Slc26a4 function. Mice were then subjected to audiologic assessments, a battery of vestibular evaluations, inner ear morphological studies, and noise exposure experiments. The results were unexpected; both Slc26a4^{tm2Dontuh/tm2Dontuh} and Slc26a4^{tm1Dontuh/tm2Dontuh} mice showed normal audiovestibular phenotypes and inner ear morphology, and they did not show significantly higher shifts in hearing thresholds after noise exposure than the wild-type mice. The results indicated not only the p.H723R allele was non-pathogenic in mice, but also a single p.H723R allele was sufficient to maintain normal inner ear physiology in heterozygous compound mice. There might be discrepancies in the pathogenicity of specific SLC26A4 mutations in humans and mice; therefore, precautions should be taken when extrapolating the results of animal studies to humans.

Citation: Lu Y-C, Wu C-C, Yang T-H, Lin Y-H, Yu I-S, Lin S-W, et al. (2013) Differences in the Pathogenicity of the p.H723R Mutation of the Common Deafness-Associated SLC26A4 Gene in Humans and Mice. PLoS ONE 8(6): e64906. https://doi.org/10.1371/journal.pone.0064906

Editor: Mark S. Shapiro, University of Texas Health Science Center, United States of America

Received: January 1, 2013; Accepted: April 19, 2013; Published: June 3, 2013

Copyright: © 2013 Lu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This study was supported by research grants from the National Health Research Institute (NHRI-EX101-10147PI), National Science Council of the Executive Yuan of the Republic of China (NSC-99-2314-B-002-056-MY3), and National Taiwan University Hospital (NTUH-100-001597). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Mutations in the SLC26A4 (PDS, GeneID: 5172) gene are the second most frequent cause of human hereditary hearing impairment worldwide, next to mutations in the GJB2 (GeneID: 2706) gene [1]. In some populations, SLC26A4 mutations can be identified in approximately 13–14% of deaf patients [2]. SLC26A4 encodes pendrin, an iodide/chloride/bicarbonate transporter expressed in the inner ear [3], thyroid [4], kidney [5], [6], salivary duct [7], and respiratory tract [8]. Recessive SLC26A4 mutations contribute to both Pendred syndrome (PS; MIM #274600) [9] and nonsyndromic hearing loss (DFNB4; MIM #600791) [10], which share the phenotypes of sensorineural hearing impairment (SNHI) accompanied by an enlarged vestibular aqueduct (EVA; MIM 603545) and/or incomplete partition of the cochlea (i.e., Mondini dysplasia), although the phenotype of PS also includes goiter. To date, more than 100 SLC26A4 mutations have been identified (Pendred/BOR Homepage; www.healthcare.uiowa.edu/labs/pendredandbor). Previous reports have described that different SLC26A4 genotypes were correlated with distinct clinical phenotypes, and patients with PS are more likely to have 2 SLC26A4 mutant alleles than those with DFNB4 [11], [12]. Many affected patients suffer from progressive or fluctuating hearing loss [13], implying that the natural course can be halted with preventive or therapeutic measures if the pathogenetic mechanisms of SLC26A4 mutations are better elucidated.

In recent years, the understanding of the pathogenesis of DFNB4 and PS has been accelerated by various mouse models with mutations in the Slc26a4 (GeneID: 23985) gene. Certain mouse models revealed congenital profound hearing loss, including the knock-out Slc26a4^−/− mice [14], the Slc26a4^loop/loop mice with the p.S408F mutation [15], and the Slc26a4^{tm1Dontuh/tm1Dontuh} mice with the c.919-A>G mutation that we previously reported [16]. The conditional knock-out Tg[E];Tg[R];Slc26a4^Δ/Δ mice demonstrated hearing loss of various severity dependent on the time of Slc26a4 expression, with doxycycline initiation at E18.5 resulting in partial hearing loss [17]. These mouse models have provided excellent insight into the pathogenesis; however, 2 basic problems might hurdle the bench-to-bedside translation. First, similar to their human counterparts, mice with different mutations, to some extent, demonstrated different phenotypes, indicating that the pathology associated with each distinct mutation is different. Second, to date, no mouse model that can perfectly simulate the progressive or fluctuating hearing loss in humans has been reported. Investigating mice with other Slc26a4 mutations might tackle these problems. Accordingly, in this study, we generated a knock-in mouse model with the p.H723R (c.2168A>G) mutation, a common SLC26A4 mutation in the East Asian population [18]–[22], and then, we characterized the associated audiovestibular phenotypes as well as the inner ear pathology.

Materials and Methods

Construction of Slc26a4^{tm2Dontuh/tm2Dontuh} Knock-in Mice

The mutation gene-targeting vector was constructed using a recombineering approach previously developed by Dr. Copeland’s group [23], [24]. From the bMQ323G13 BAC clone (Sanger Institute, Cambridge, UK), we subcloned a 12.8-kb fragment spanning introns 17–21 of Slc26a4 into the PL253 plasmid (Fig. 1A). The subcloned genomic 12.8-kb region was modified in a subsequent targeting round by inserting the neomycin (neo) cassette from the PL452 plasmid and creating the c.2168A>G mutation in exon 19. The targeting vector was then linearized by NotI digestion and electroporated into R1 embryonic stem (ES) cells. G418 (240 µg/mL) and ganciclovir (2 µM) double-resistant clones were analyzed by Southern blot hybridization (Fig. 1B). The retained neo cassette flanked by loxP sites was excised in vivo by transfecting the targeted clone with plasmid transiently expressing the Cre recombinase. Established ES clones were then identified by polymerase chain reaction (PCR) screening and subsequently injected into C57BL/6 blastocysts to produce chimeras. After germline transmission of the targeted mutation allele, we produced the congenic Slc26a4^+/tm2Dontuh mouse line used in this study by repeated backcrossing into the C57BL/6 inbred strain for 6–10 generations, after which mice homozygous for the mutation (i.e., Slc26a4^{tm2Dontuh/tm2Dontuh}) were obtained by intercrossing heterozygous mice (i.e., Slc26a4^+/tm2Dontuh) (Fig. 1C). Reverse transcription-PCR (RT-PCR) of mRNA of inner ear extract followed by direct sequencing also indicated a pure non-chimeric genetic background without unintentionally wild-type Slc26a4 expression in Slc26a4^{tm2Dontuh/tm2Dontuh} mice. Corresponding to the human genotypes, mice with compound heterozygous mutations for p.H723R and c.919-2A>G (i.e., Slc26a4^{tm1Dontuh/tm2Dontuh}) were also generated by intercrossing heterozygous Slc26a4^+/tm2Dontuh mice with Slc26a4^{tm1Dontuh/tm1Dntuh} mice. All animal experiments were carried out in accordance with animal welfare guidelines and approved by the Institutional Animal Care and Use Committee (IACUC) of National Taiwan University College of Medicine (approval no. 20110123).

Download:

Figure 1. Generation of mice with the Slc26a4 p.H723R mutation.

(A) Targeting scheme. A BAC clone (clone no. bMQ-323G13 Geneservice™) from the 129S7/AB2.2 BAC library containing the mouse Slc26a4 genomic region was used to construct the targeting vector. (1) Restriction map of the wild-type genomic mouse Slc26a4 locus. The expected size of the XbaI restriction fragment was 12.8 kb. (2) Targeting vector (TV) construction. The loxP-flanked neomycin resistance gene (neo) was used as a selection marker during embryonic stem (ES) cell culture. The c.2168 A>G mutation in exon 19 is labeled with a star. (3–4) The targeted locus was introduced, and then, the neo cassette was removed. LA, long arm; SA, short arm. (B) Southern blot analysis of ES cell clones. Genomic DNA from 2 targeted and 2 wild-type clones were digested with XbaI and hybridized with the probe to verify the targeting event. (C) DNA sequencing of Slc26a4^+/+ and Slc26a4^{tm2Dontuh/tm2Dontuh} mice. The electrophoretogram shows the p.H723R mutation. The A to G mutation (arrow) at position 2168 led to the replacement of a histidine (His, H) residue at position 723 with arginine (Arg, R).

https://doi.org/10.1371/journal.pone.0064906.g001

Audiological and Vestibular Evaluations

For audiological evaluations, the mice were anesthetized with sodium pentobarbital (35 mg/kg) delivered intraperitoneally and placed in a head-holder within an acoustically and electrically insulated and grounded test room. We used an evoked potential detection system (Smart EP 3.90; Intelligent Hearing Systems, Miami, FL, USA) to measure the thresholds of the auditory brainstem response (ABR) in mice. Click sounds, as well as 8, 16, and 32 kHz tone bursts at varying intensity, were generated to evoke ABRs in mice. The response signals were recorded with subcutaneous needle electrodes. The active electrodes were inserted into the vertex and the ipsilateral retro-auricular region with a ground electrode on the back of the mice.

For vestibular evaluations, mice were subjected to a battery of tests, including observation of their circling behavior and head tilting (performed at 3 weeks of age), reaching test, swimming test, gripping test, and a rotarod test (all performed at 8 weeks of age). The methodology of each vestibular test is described in details in our previous study [16].

Inner Ear Morphology Studies

Tissues from the inner ears of mice were subjected to hematoxylin and eosin (H&E) staining, and the morphology of each sample was examined with a Leica optical microscope. For both light microscopy and scanning electron microscopy (SEM) studies, inner ears from adult mice were fixed by perilymphatic perfusion with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) through round and oval windows and a small fenestra in the apex of the cochlear bony capsule. Specimens were subsequently rinsed in PBS buffer and decalcified in 4% PFA with 0.35 M EDTA at 4°C for 1 week. For light microscopy studies, the samples were dehydrated and embedded in paraffin. Subsequently, serial sections (7 µm) were stained with H&E. For SEM studies, the samples were dehydrated in ethanol, critical-point dried, gold sputter coated, and then examined in a field emission scanning electron microscope (S-4500; Hitachi, Tokyo, Japan).

Whole-mount studies of mouse inner ear specimens were performed as previously described [25] with some minor modifications. Briefly, after perfusion with 4% PFA, the cochleae were postfixed in the same solution for 2 h at room temperature and washed in PBS. The samples were permeabilized in 1% Triton X-100 for 30 min and washed with PBS, followed by overnight incubation at 4°C in the blocking solution. The tissues were then stained with rhodamine-phalloidin (1∶100 dilution; Molecular Probes, Eugene, OR, USA). After washing in PBS, the tissues were mounted using the ProLong Antifade kit (Molecular Probes, Eugene, OR, USA) for 20 min at room temperature. Images of the tissues were obtained using a laser scanning confocal microscope (Zeiss LSM 510; Germany).

Expression of Pendrin

For pendrin expression experiments, we prepared tissue sections from the inner ears of Slc26a4^{tm1Dontuh/tm2Dontuh} and Slc26a4^{tm2Dontuh/tm2Dontuh} mice. Tissue sections mounted on silane-coated glass slides were then deparaffinized in xylene and rehydrated in ethanol. After antigen heat retrieval (500 W microwave oven, in 10 mm citric buffer, pH 6.0, for 20 min), the slides were incubated overnight at 4°C with primary antibodies in PBS and Tween (PBST) (rabbit anti-pendrin, 1∶100 [H195]; mouse anti-Myosin VIIa, 1∶100 [C-5]; Santa Cruz Biotechnology, Santa Cruz, CA, USA). The slides were then washed and incubated for 1 h at 25°C with appropriate secondary antibodies at a 1∶1000 dilution in PBST. After incubation, the slides were washed with PBST and mounted with the ProLong Antifade kit at 25°C. Images were obtained using a laser scanning confocal microscope (Zeiss LSM 510; Germany).

Real-time PCR

Total RNA was purified using Trizol reagent (Invitrogen, CA, USA) according to the manufacturer’s protocol and stored at −80°C until further use. Total RNA was treated with DNase and then reverse transcribed into first-strand cDNA in a 20-µL reaction volume using SuperScript III Reverse Transcriptase (Invitrogen, CA, USA). Quantitative real-time reverse transcription (RT)-PCR assays of Kcnj10 cDNA were performed using a gene-specific double fluorescently labeled TaqMan probe in an ABI Prism 7900 Sequence Detection System (Applied Biosystems) in accordance with the manufacturer’s recommendations. The relative mRNA expression level was determined by the 2^−ΔΔCt analysis method, and calculations were performed using the software provided by the manufacturer (Applied Biosystems). Specimens from 5 mice were collected for each experiment, and the experiments were performed in triplicates and averaged. The average mRNA expression level in wild-type mice was normalized to 1 as the control.

Western Blot Analysis

Protein extracts of the inner ear were homogenized in RIPA buffer (Millipore, MO, USA). Equal amounts of proteins were supplemented with dithiothreitol, heated for 5 min at 95°C, separated by SDS gel electrophoresis, and then transferred to a PVDF membrane (Amersham Pharmacia Biotech, Little Chalfont, UK) by semi-dry electroblotting. The PVDF membranes were developed with an enhanced chemiluminescence western blot detection kit (Pierce SuperSignal® West Dura, Rockford, IL, USA) and exposed to Lumi-Film chemiluminescent detection films (Roche Diagnostics, Mannheim, Germany). The specimens were collected from 5 mice for each experiment, and the experiments were performed in triplicates and averaged. The average protein expression level in wild-type mice was normalized to 1 as the control.

Noise Exposure Experiments

For the noise exposure experiments, 10 mice of each genotype were exposed for 3 h to octave-band noise with a peak at 4 kHz, 115 dB SPL. The noise room was fitted with a speaker (model NO. 1700–2002, GSI) driven by a noise generator (GSI-61; Grason-Stadler, Inc.) and a power amplifier (5507-Power; TECHRON). ABR thresholds (dB SPL) in mice at different frequencies (click, 8 kHz, 16 kHz, and 32 kHz) were then recorded at 30 min and at day 1, 2, 3, 7, and 14 after noise exposure.

Thyroid and Renal Serum Biochemistry

Terminal blood samples were obtained from mice at postnatal day 15 to compare the early postnatal T4 surge [26], as well as at 2 and 6 months of age to monitor the long-term thyroid and renal profiles. Total T4 was measured in undiluted serum (25 µL) by RIA (Diagnostic Products Corp., Los Angeles, CA, USA). Thyroid-stimulating hormone (TSH), Blood urea nitrogen (BUN) and serum creatinine (CREA) were measured by the research services of National Taiwan University Hospital.

Results

Audiological and Vestibular Phenotypes

Wild-type mice (i.e., Slc26a4^+/+), heterozygous mice (i.e., Slc26a4^+/tm2Dontuh), and homozygous mice (i.e., Slc26a4^{tm2Dontuh/tm2Dontuh}) (n = 10 each) were subjected to audiological evaluations at 1, 3, 6, and 9 months. Both Slc26a4^+/tm2Dontuh and Slc26a4^{tm2Dontuh/tm2Dontuh} mice had normal hearing up to 9 months (Fig. 2), indicating that the p.H723R allele does not lead to deafness in mice. To verify the pathogenicity of the p.H723R allele in mice, we further generated mice with compound heterozygous mutations (i.e., Slc26a4^{tm1Dontuh/tm2Dontuh}) by intercrossing Slc26a4^+/tm2Dontuh mice with Slc26a4^{tm1Dontuh/tm1Dontuh} mice, which segregated the c.919-2A>G mutation with an abolished function [16]. Similar to the mice heterozygous for the c.919-2A>G mutation (i.e., Slc26a4^+/tm1Dontuh), Slc26a4^{tm1Dontuh/tm2Dontuh} mice (n = 10) had normal hearing up to 9 months; this finding confirmed that the p.H723R allele was not pathogenic and a single p.H723R allele was sufficient to maintain normal hearing in mice.

Download:

Figure 2. Hearing thresholds (dB SPL) of different frequencies (clicks, 8, 16, and 32 kHz) at 1, 3, 6, and 9 months in mice with different genotypes.

Heterozygous mice (i.e., Slc26a4^+/tm2Dontuh), homozygous mice (i.e., Slc26a4^{tm2Dontuh/tm2Dontuh}), and compound heterozygous mice (i.e., Slc26a4^{tm1Dontuh/tm2Dontuh}) showed normal hearing as wild type mice (Slc26a4^+/+ ) up to 9 months.

https://doi.org/10.1371/journal.pone.0064906.g002

A total of 60 mice, including Slc26a4^+/+ mice, Slc26a4^+/tm2Dontuh mice, Slc26a4^{tm2Dontuh/tm2Dontuh} mice, and Slc26a4^{tm1Dontuh/tm2Dontuh} mice (n = 15 each), were subjected to vestibular evaluations (Table S1). Similar to the normal audiological phenotypes, neither heterozygous mice (i.e., Slc26a4^+/tm2Dontuh) nor homozygous mice (i.e., Slc26a4^{tm2Dontuh/tm2Dontuh}) showed vestibular deficits such as head tilting and circling behavior, and both groups performed normally on reaching, swimming, gripping, and rotarod tests. Similarly, compound heterozygous mice (i.e., Slc26a4^{tm1Dontuh/tm2Dontuh}) also did not show vestibular deficits, indicating that a single p.H723R allele was sufficient to maintain normal vestibular function in mice.

Cochlear Morphology

Cochlear morphology was investigated in homozygous mice (i.e., Slc26a4^{tm2Dontuh/tm2Dontuh}) and compound heterozygous mice (i.e., Slc26a4^{tm1Dontuh/tm2Dontuh}). The cochlear morphologies of wild-type mice and the profoundly deaf Slc26a4^{tm1Dontuh/tm1Dontuh} mice were also compared. Abnormal morphological findings in Slc26a4^{tm1Dontuh/tm1Dontuh} mice, such as severe endolymphatic hydrops with dilatation of the scala media (Fig. 3B), significant atrophy of the stria vascularis (Fig. 3B), and degeneration of the cochlear hair cells (Fig. 3E), were not observed in Slc26a4^{tm2Dontuh/tm2Dontuh} mice (Fig. 3C and 3F) and Slc26a4^{tm1Dontuh/tm2Dontuh} mice (Fig. 3D and 3G).

Download:

Figure 3. Comparison of Cochlear morphology in mice with different genotypes at P60.

Compared with cochlear morphology in Slc26a4^+/+ mice (A), severe endolymphatic hydrops (dilatation of scala media) and a significant atrophy of the stria vascularis (B), as well as degenerated hair cells (E), were observed in Slc26a4^{tm1Dontuh/tm1Dontuh} mice. In contrast, normal cochlear morphology was revealed in both Slc26a4^{tm2Dontuh/tm2Dontuh} mice (C) and Slc26a4^{tm1Dontuh/tm2Dontuh} mice (D). No degeneration of cochlear hair cells at the basal turn was observed in Slc26a4^{tm2Dontuh/tm2Dontuh} mice (F) and Slc26a4^{tm1Dontuh/tm2Dontuh} mice (G). IHC: inner hair cells; OHC: outer hair cells; RM: Reissner’s membrane; SV: stria vascularis; A, B, C, D: hematoxylin and eosin (H&E) staining; E, F, G: fluorescence confocal microscopy; Bar = 150 µm (A–D) and 20 µm (E–G).

https://doi.org/10.1371/journal.pone.0064906.g003

Vestibular Morphology

The vestibular morphology was investigated in homozygous mice (i.e., Slc26a4^{tm2Dontuh/tm2Dontuh}) (Fig. 4A, 4B, and 4C) and compound heterozygous mice (i.e., Slc26a4^{tm1Dontuh/tm2Dontuh}) (Fig. 4D, 4E, and 4F). Both mice showed normal morphological findings and amount of otoconia in the vestibule. Fluorescence confocal microscopy revealed that vestibular hair cells in Slc26a4^{tm2Dontuh/tm2Dontuh} mice and Slc26a4^{tm1Dontuh/tm2Dontuh} mice were not degenerated (Fig. 4G and 4I). SEM revealed normal otoconia at the utricle in Slc26a4^{tm2Dontuh/tm2Dontuh} mice and Slc26a4^{tm1Dontuh/tm2Dontuh} mice (Fig. 4H and 4J).

Download:

Figure 4. Comparison of Vestibular morphology in mice with different genotypes at P60 (Slc26a4^{tm2Dontuh/tm2Dontuh} mice: A, B, C, G, H; Slc26a4^{tm1Dontuh/tm2Dontuh} mice: D, E, F, I, J).

Normal morphological findings and amount of otoconia in the vestibule (arrowhead) are shown in both mice (A, B, C, D, E, F). No degeneration of vestibular hair cells in both mice is observed by fluorescence confocal microscopy (G, H). Scanning electron microscopic findings show normal otoconia at the utricle in both mice (I, J). Bar = 50 µm (A–F) and 10 µm (G–H).

https://doi.org/10.1371/journal.pone.0064906.g004

Immunolocalization and Expression of Pendrin

We then investigated the expression of pendrin in the cochlea of Slc26a4^{tm2Dontuh/tm2Dontuh} mice and Slc26a4^{tm1Dontuh/tm2Dontuh} mice (Fig. 5A) by immunolocalization. In both strains of mice, pendrin was normally distributed in the spiral prominence and root cells, indicating that the expression of pendrin was not affected by the p.H723R mutation in mice. Compared with the wild-type mice, no significant difference in the molecular weight (Fig. 5B) or the expression level (Fig. 5C) of pendrin were observed in Slc26a4^{tm2Dontuh/tm2Dontuh} mice and Slc26a4^{tm1Dontuh/tm2Dontuh} mice by western blotting analyses.

Download:

Figure 5. Expression of pendrin and Kcnj10.

(A) Pendrin is normally distributed in the spiral prominence and root cells (stained in green) in Slc26a4^+/+ (left), Slc26a4^{tm2Dontuh/tm2Dontuh} (middle), and Slc26a4^{tm1Dontuh/tm2Dontuh} mice (right), indicating that the expression of pendrin is not affected by the p.H723R mutation in mice. (B) Immunoblotting of pendrin expression at P42. Both Slc26a4^{tm2Dontuh/tm2Dontuh} and Slc26a4^{tm1Dontuh/tm2Dontuh} mice expressed pendrin of molecular weight comparable to the wild-type mice, indicating that the glycosylation process remained unaffected in the p.H723R-pendrin. (C) Quantification of pendrin protein expression at P42. The expression levels of pendrin in Slc26a4^{tm2Dontuh/tm2Dontuh} mice and Slc26a4^{tm1Dontuh/tm2Dontuh} mice were 0.89±0.18 and 1.08±0.13, showing no significant difference as compared with 1.00±0.11 in Slc26a4^+/+ mice (mean percentage ± SE, n = 3). (D) Quantification of mRNA expression of Kcnj10 at P15 by real-time PCR. Slc26a4^{tm2Dontuh/tm2Dontuh} mice and Slc26a4^{tm1Dontuh/tm2Dontuh} mice did not show significantly different mRNA levels of Kcnj10 as compared with Slc26a4^+/+ mice. (E) Quantification of Kcnj10 protein expression at P15 by western blotting. The expression levels of Kcnj10 protein in Slc26a4^{tm2Dontuh/tm2Dontuh} mice and Slc26a4^{tm1Dontuh/tm2Dontuh} mice were 0.90±0.19 and 0.90±0.17, showing no significant difference as compared with 1.00±0.12 in Slc26a4^+/+ mice (mean percentage ± SE, n = 3). RC: root cells; SP: spiral prominence; SL: spiral ligament; SV: stria vascularis; Bar = 20 µm.

https://doi.org/10.1371/journal.pone.0064906.g005

Kcnj10 Expression

We then investigated the expression of Kcnj10 (GeneID: 16513) in Slc26a4^+/+mice, Slc26a4^{tm2Dontuh/tm2Dontuh} mice, and Slc26a4^{tm1Dontuh/tm2Dontuh} mice by real-time PCR (for mRNA expression) and western blotting (for protein expression) analyses. It has been demonstrated that_Slc26a4-depleted mice showed decreased Kcnj10 expression, which contributes to the failure of endocochlear potential generation [27]. KCNJ10 (GeneID: 3766) mutations have been observed in EVA patients via digenic inheritance with SLC26A4 mutations [28]. In this study, the stria vascularis of P15 mouse cochleae from Slc26a4^+/+ mice, Slc26a4^{tm2Dontuh/tm2Dontuh} mice, and Slc26a4^{tm1Dontuh/tm2Dontuh} mice were isolated by microdissection, and total RNA and protein extracted from these tissue fractions were used for real-time PCR and quantitative immunoblot analyses. Compared with the wild-type mice, no significant differences in the mRNA (Fig. 5D) or protein levels of Kcnj10 (Fig. 5E) were observed in Slc26a4^{tm2Dontuh/tm2Dontuh} mice and Slc26a4^{tm1Dontuh/tm2Dontuh} mice.

Noise Exposure Experiments

We then attempted to induce audiologic phenotypes in transgenic mice with noise exposure [29]. Neither Slc26a4^{tm2Dontuh/tm2Dontuh} mice nor Slc26a4^{tm1Dontuh/tm2Dontuh} mice showed a significantly higher shift in hearing thresholds at all frequencies 30 min and at day 1, 2, 3, 7, and 14 after noise exposure than Slc26a4^+/+ mice (Fig. 6); this finding confirmed their normal audiologic phenotypes.

Download:

Figure 6. Chronological change of hearing thresholds (dB SPL) of different frequencies (clicks, 8, 16, and 32 kHz) in mice with different genotypes.

Neither Slc26a4^{tm2Dontuh/tm2Dontuh} mice nor Slc26a4^{tm1Dontuh/tm2Dontuh} mice had a significantly higher shift in hearing thresholds at any of the frequencies at 30 min or at day 1, 2, 3, 7, and 14 after noise exposure as compared with Slc26a4^+/+ mice.

https://doi.org/10.1371/journal.pone.0064906.g006

Thyroid and Renal Profiles

Goiter was not observed in Slc26a4^+/+ mice, Slc26a4^{tm2Dontuh/tm2Dontuh} mice, and Slc26a4^{tm1Dontuh/tm2Dontuh} mice (n = 5 each) until the mice were 6-months old. Blood chemistry, including total T4, TSH, BUN, and CREA, were all within normal limits at postnatal day 15, 2 and 6 months (Table S2).

Discussion

In this study, we generated a knock-in mouse model, denoted as Slc26a4^{tm2Dontuh/tm2Dontuh} mice, which segregates the common deafness-associated p.H723R mutation in humans. The p.H723R mutation was found in both nonsyndromic EVA and PS families [18], [30]. This missense mutation was the most prevalent SLC26A4 mutation among the Japanese [18] and Koreans [19], and the second most prevalent SLC26A4 mutation among the Han Chinese [20], [21]. Recent reports indicated that the p.H723R mutation arose from a common ancestor and was not a mutational hot spot [31]. The pathogenicity of the p.H723R mutation in humans was confirmed by several lines of evidence supporting the fact that p.H723R co-segregated with the phenotypes in the affected families, the prevalence of p.H723R was low in the control populations, and the p.H723 amino acid residue was evolutionally conserved [18]. Moreover, in human cell lines, the p.H723R has been related to trafficking/folding/glycosylation defects of the pendrin protein. In transfected HEK293 cells and HeLa cells, p.H723R caused protein retention in endoplasmic reticulum and abolished complex glycosylation of pendrin, and the defects in protein processing could be restored considerably by low temperature incubation or treatment with sodium butyrate [32]. Further study revealed the folding defect in the p.H723R-pendrin, and treatment of salicylate, which functioned as a pharmacological chaperone, could restore normal protein localization and anion exchange activity [33].

Interestingly, as shown in the present study, both heterozygous mice (i.e., Slc26a4^+/tm2Dontuh) and homozygous mice (i.e., Slc26a4^{tm2Dontuh/tm2Dontuh}) with the knock-in p.H723R mutation had normal audiovestibular phenotypes, including normal hearing thresholds up to 9 months, excellent balancing ability, and an intact cochlear and vestibular morphology. There are several possibilities why the p.H723R mutation did not lead to the expected abnormal phenotype in mice. The first possibility is that the abnormal phenotype was present but not yet discovered or that the abnormal phenotype will become evident only under certain environmental conditions [34]. Although this possibility could not be completely ruled out by the results of this study, it was largely weakened after an exhaustive investigation of the audiovestibular phenotypes, including examination of hearing levels up to 9 months, a battery of vestibular tests, comprehensive inner ear morphological studies, and noise exposure experiments. The second possibility is that the phenotypic effects of the p.H723R mutation are influenced by the genetic background of the mice [35]. This was also unlikely; as in our previous study, we generated a knock-in Slc26a4 mouse model with abnormal audiovestibular phenotypes by using the same C57BL/6 strain. Another possibility, which became the most likely scenario for our study after the former 2 possibilities were refuted, is that, there are, in fact, no abnormal phenotypes.

In particular, the absence of abnormal audiovestibular phenotypes in homozygous mice alone is not sufficient to exclude the pathogenicity of p.H723R in mice because the function of the Slc26a4 p.H723R mutation might be only partially defective, and even harboring 2 p.H723R alleles might still maintain adequate Slc26a4 function. To elucidate the pathogenicity of the p.H723R allele, we further generated mice with compound heterozygous mutations (i.e., Slc26a4^{tm1Dontuh/tm2Dontuh}) by intercrossing Slc26a4^+/tm2Dontuh mice with Slc26a4^{tm1Dontuh/tm1Dontuh} mice, which segregated the c.919-2A>G mutation with abolished function. Mice that were compound heterozygous for p.H723R and c.919-2A>G (i.e., Slc26a4^{tm1Dontuh/tm2Dontuh}) had normal audiovestibular phenotypes, indicating that a single p.H723R allele was sufficient to maintain normal inner ear physiology. Moreover, the expression of the downstream Kcnj10 gene, which diminished at P10–P15 following oxidative stress in Slc26a4^−/− mice [36], was not compromised in Slc26a4^{tm2Dontuh/tm2Dontuh} mice and Slc26a4^{tm1Dontuh/tm2Dontuh} mice. These findings indicate that the p.H723R allele is neither pathogenic in mice nor is a mutation with partially ablated function.

As shown in Figure 5, both Slc26a4^{tm2Dontuh/tm2Dontuh} and Slc26a4^{tm1Dontuh/tm2Dontuh} mice expressed pendrin of molecular weight and expression level comparable to the wild-type mice, indicating that the trafficking/glycosylation process remained unaffected in the murine p.H723R-pendrin. The difference in the intactness of the trafficking/glycosylation process might contribute to the variation in the pathogenicity of p.H723R between mice and humans. We further analyzed the amino-acid sequences of human and mouse pendrin using ConSeq (http://conseq.tau.ac.il/), a website server predicting biologically important residues in protein [37]. Possibly the intact trafficking/glycosylation process of p.H723R in mice might be attributed to a different alignment of amino acid residues in the vicinity, as well as the embedded location of p.H723 in the pendrin (Fig. S1).

Four other mouse models with Slc26a4 mutations have been reported: knock-out Slc26a4^−/− mice [14], Slc26a4^loop mice with the p.S408F mutation generated by ENU mutagenesis [15], Slc26a4^tm1Dontuh knock-in mice with the common East Asian c.919-2A>G mutation [16], and conditional knock-out Tg[E];Tg[R];Slc26a4^Δ/Δ mice [17] (Table 1). Slc26a4^−/− mice are profoundly deaf with significant vestibular deficits and have EVA and scala media, mimicking the phenotypes in humans [14]. Subsequent research on Slc26a4^loop mice [15] and Slc26a4^{tm1Dontuh/tm1Dontuh} mice [16] reported similar auditory and vestibular characteristics, complementing the studies on Slc26a4^−/− mice. To better simulate the less severe audiological phenotype in humans, Choi et al. generated a binary transgenic mouse line in which Slc26a4 expression could be induced with doxycycline. The authors identified that the E16.5 to P2 was the critical interval in which pendrin was required for acquisition of normal hearing, and demonstrated that doxycycline initiation at E18.5 or discontinuation at E17.5 resulted in partial hearing loss, instead of the profound hearing loss observed in the knock-out Slc26a4^−/− mice [17]. In contrast, Slc26a4^{tm2Dontuh/tm2Dontuh} mice examined in this study had normal audiovestibular phenotypes, representing a distinct and unique mouse strain compared with the other mouse models reported in the literature.

Download:

Table 1. Comparison of phenotypes among mouse strains segregating different Slc26a4 mutations.

https://doi.org/10.1371/journal.pone.0064906.t001

Among humans, patients with PS are more likely to have 2 SLC26A4 mutant alleles than those with nonsyndromic EVA [11], [12]. Moreover, the number of SLC26A4 mutant alleles is significantly correlated with the severity of hearing loss in individuals with EVA [38], [39]. However, because of its diverse mutation spectrum, it is difficult to delineate the phenotypes associated with a specific SLC26A4 mutation in humans. Consequently, determining the pathogenetic mechanisms of each specific SLC26A4 mutation largely relies on functional studies performed in Xenopus oocytes [40] or cell lines [41], [42]. The observation that mice with distinct Slc26a4 mutations have different phenotypes indicates that transgenic mice may serve as appropriate, direct models to investigate corresponding SLC26A4 mutations in humans.

In conclusion, using a genotype-driven approach, we generated a knock-in mouse model segregating the common deafness-associated SLC26A4 p.H723R mutation in humans. To our surprise, mice with the Slc26a4 p.H723R mutation had a normal audiovestibular phenotype and inner ear morphology. Because there might be differences in the pathogenicity of specific SLC26A4 mutations in humans and mice, precaution should be taken when extrapolating the results of animal studies to humans.

Supporting Information

Figure S1.

Alignment of amino-acid sequences of human and mouse pendrin. The amino-acid sequence (a.a. 651–780) of human pendrin (hum-pendrin) was aligned in relative to the sequence of the mouse pendrin (mse-pendrin) using Conseq. Arrows indicate the p.H723 position. The p.H723 is a highly conserved but buried amino acid residue. Different alignments of amino acid residues in the vicinity of p.H723 and the embedded location of p.H723 in the pendrin might contribute to the variation in the pathogenicity of p.H723R between mice and humans. The first row below the sequence lists the predicted burial status of the site (b, buried; e, exposed). The second row indicates residues predicted to be structurally (s) and functionally (f) important.

https://doi.org/10.1371/journal.pone.0064906.s001

(TIF)

Table S1.

Comparison of vestibular features according to the genotypes and the circling behavior.

https://doi.org/10.1371/journal.pone.0064906.s002

(DOCX)

Table S2.

Blood chemistry of Slc26a4 male mice at postnatal day 15, 2 and 6 months of age.

https://doi.org/10.1371/journal.pone.0064906.s003

(DOCX)

Acknowledgments

We thank the staff of the Eighth Core Lab, Department of Medical Research, National Taiwan University Hospital for technical support in performing functional genetic studies. We are also grateful to the Transgenic Mouse Model Core Facility of the National Core Facility Program for Biotechnology, National Science Council and the Gene Knockout Mouse Core Laboratory of National Taiwan University Center of Genomic Medicine for the generation of the transgenic mice.

Author Contributions

Conceived and designed the experiments: YCL CCW CJH. Performed the experiments: YCL THY YHL. Analyzed the data: YCL CCW JMW. Contributed reagents/materials/analysis tools: ISY SWL QC XL. Wrote the paper: YCL CCW CJH.

References

1. Hilgert N, Smith RJ, Van Camp G (2009) Forty-six genes causing nonsyndromic hearing impairment: Which ones should be analyzed in DNA diagnostics? Mutat Res 681: 189–196.
- View Article
- Google Scholar
2. Wu CC, Chen PJ, Chiu YH, Lu YC, Wu MC, et al. (2008) Prospective mutation screening of three common deafness genes in a large Taiwanese Cohort with idiopathic bilateral sensorineural hearing impairment reveals a difference in the results between families from hospitals and those from rehabilitation facilities. Audiol Neurootol 13: 172–181.
- View Article
- Google Scholar
3. Everett LA, Morsli H, Wu DK, Green ED (1999) Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear. Proc Natl Acad Sci U S A 96: 9727–9732.
- View Article
- Google Scholar
4. Royaux IE, Suzuki K, Mori A, Katoh R, Everett LA, et al. (2000) Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 141: 839–845.
- View Article
- Google Scholar
5. Royaux IE, Karniski LP, Everett LA, Knepper MA, Green ED, et al. (2001) Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci U S A 98: 4221–4226.
- View Article
- Google Scholar
6. Soleimani M, Greeley T, Petrovic S, Wang ZH, Amlal H, et al. (2001) Pendrin: an apical Cl(−)/OH(−)/HCO(3)(−) exchanger in the kidney cortex. Am J Physiol Renal Physiol 280: F356–364.
- View Article
- Google Scholar
7. Shcheynikov N, Yang DK, Wang YX, Zeng WZ, Karniski LP, et al. (2008) The Slc26a4 transporter functions as an electroneutral Cl(−)/I(−)/HCO(3)(−) exchanger: role of Slc26a4 and Slc26a6 in I(−) and HCO(3)(−) secretion and in regulation of CFTR in the parotid duct. J Physiol 586: 3813–3824.
- View Article
- Google Scholar
8. Nakao I, Kanaji S, Ohta S, Matsushita H, Arima K, et al. (2008) Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease. J Immunol 180: 6262–6269.
- View Article
- Google Scholar
9. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, et al. (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17: 411–422.
- View Article
- Google Scholar
10. Li XC, Everett LA, Lalwani AK, Desmukh D, Friedman TB, et al. (1998) A mutation in PDS causes non-syndromic recessive deafness. Nat Genet 18: 215–217.
- View Article
- Google Scholar
11. Pryor SP, Madeo AC, Reynolds JC, Sarlis NJ, Arnos KS, et al. (2005) SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities. J Med Genet 42: 159–165.
- View Article
- Google Scholar
12. Azaiez H, Yang T, Prasad S, Sorensen JL, Nishimura CJ, et al. (2007) Genotype-phenotype correlations for SLC26A4-related deafness. Hum Genet 122: 451–457.
- View Article
- Google Scholar
13. Mori T, Westerberg BD, Atashband S, Kozak FK (2008) Natural history of hearing loss in children with enlarged vestibular aqueduct syndrome. J Otolaryngol Head Neck Surg 37: 112–118.
- View Article
- Google Scholar
14. Everett LA, Belyantseva IA, Noben-Trauth K, Cantos R, Chen A, et al. (2001) Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet 10: 153–161.
- View Article
- Google Scholar
15. Dror AA, Politi Y, Shahin H, Lenz DR, Dossena S, et al. (2010) Calcium oxalate stone formation in the inner ear as a result of an Slc26a4 mutation. J Biol Chem 28: 21724–21735.
- View Article
- Google Scholar
16. Lu YC, Wu CC, Shen WS, Yang TH, Yeh TH, et al. (2011) Establishment of a knock-in mouse model with the SLC26A4 c.919–2A>G mutation and characterization of its pathology. PLoS One 6: e22150.
- View Article
- Google Scholar
17. Choi BY, Kim HM, Ito T, Lee KY, Li XM, et al. (2011) Mouse model of enlarged vestibular aqueducts defines temporal requirement of Slc26a4 expression for hearing acquisition. J Clin Invest 121: 4516–4525.
- View Article
- Google Scholar
18. Tsukamoto K, Suzuki H, Harada D, Namba A, Abe S, et al. (2003) Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese. Eur J Hum Genet 11: 916–922.
- View Article
- Google Scholar
19. Park HJ, Lee SJ, Jin HS, Lee JO, Go SH, et al. (2005) Genetic basis of hearing loss associated with enlarged vestibular aqueducts in Koreans. Clin Genet 67: 160–165.
- View Article
- Google Scholar
20. Wu CC, Yeh TH, Chen PJ, Hsu CJ (2005) Prevalent SLC26A4 mutations in patients with enlarged vestibular aqueduct and/or Mondini dysplasia: a unique spectrum of mutations in Taiwan, including a frequent founder mutation. Laryngoscope 115: 1060–1064.
- View Article
- Google Scholar
21. Wang QJ, Zhao YL, Rao SQ, Guo YF, Yuan H, et al. (2007) A distinct spectrum of SLC26A4 mutations in patients with enlarged vestibular aqueduct in China. Clin Genet 72: 245–254.
- View Article
- Google Scholar
22. Yuan Y, Guo W, Tang J, Zhang G, Wang G, et al. (2012) Molecular epidemiology and functional assessment of novel allelic variants of SLC26A4 in non-syndromic hearing loss patients with enlarged vestibular aqueduct in China. PLoS One 7: e49984.
- View Article
- Google Scholar
23. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, et al. (2001) A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73: 56–65.
- View Article
- Google Scholar
24. Su KY, Chien WL, Fu WM, Yu IS, Huang HP, et al. (2007) Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory. J Neurosci 27: 2513–2524.
- View Article
- Google Scholar
25. Belyantseva IA, Adler HJ, Curi R, Frolenkov GI, Kachar B (2000) Expression and localization of prestin and the sugar transporter GLUT-5 during development of electromotility in cochlear outer hair cells. J Neurosci 20: RC116.
- View Article
- Google Scholar
26. Wangemann P, Kim HM, Billings S, Nakaya K, Li X, et al. (2009) Developmental delays consistent with cochlear hypothyroidism contribute to failure to develop hearing in mice lacking Slc26a4/pendrin expression. Am J Physiol Renal Physiol 297: F1435–1447.
- View Article
- Google Scholar
27. Wangemann P, Itza EM, Albrecht B, Wu T, Jabba SV, et al. (2004) Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med 2: 30.
- View Article
- Google Scholar
28. Yang T, Gurrola JGII, Wu H, Chiu SM, Wangemann P, et al. (2009) Mutations of KCNJ10 together with mutations of SLC26A4 cause digenic nonsyndromic hearing loss associated with enlarged vestibular aqueduct syndrome. Am J Hum Genet 84: 651–657.
- View Article
- Google Scholar
29. Ohlemiller KK, Gagnon PM (2007) Genetic dependence of cochlear cells and structures injured by noise. Hear Res 224: 34–50.
- View Article
- Google Scholar
30. Sugiura M, Sato E, Nakashima T, Sugiura J, Furuhashi A, et al. (2005) Long-term follow-up in patients with Pendred syndrome: vestibular, auditory and other phenotypes. Eur Arch Otorhinolaryngol 262: 737–743.
- View Article
- Google Scholar
31. Park HJ, Shaukat S, Liu XZ, Hahn SH, Naz S, et al. (2003) Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness. J Med Genet 40: 242–248.
- View Article
- Google Scholar
32. Yoon JS, Park HJ, Yoo SY, Namkung W, Jo MJ, et al. (2008) Heterogeneity in the processing defect of SLC26A4 mutants. J Med Genet 45: 411–419.
- View Article
- Google Scholar
33. Ishihara K, Okuyama S, Kumano S, Iida K, Hamana H, et al. (2010) Salicylate restores transport function and anion exchanger activity of missense pendrin mutations. Hear Res 270: 110–118.
- View Article
- Google Scholar
34. Barbaric I, Miller G, Dear TN (2007) Appearances can be deceiving: phenotypes of knockout mice. Brief Funct Genomic Proteomic 6: 91–103.
- View Article
- Google Scholar
35. Pearson H (2002) Surviving a knockout blow. Nature 415: 8–9.
- View Article
- Google Scholar
36. Singh R, Wangemann P (2008) Free radical stress-mediated loss of Kcnj10 protein expression in stria vascularis contributes to deafness in Pendred syndrome mouse model. Am J Physiol Renal Physiol 294: F139–148.
- View Article
- Google Scholar
37. Berezin C, Glaser F, Rosenberg J, Paz I, Pupko T, et al. (2004) ConSeq: the identification of functionally and structurally important residues in protein sequences. Bioinformatics 20: 1322–1324.
- View Article
- Google Scholar
38. King KA, Choi BY, Zalewski C, Madeo AC, Manichaikul A, et al. (2010) SLC26A4 genotype, but not cochlear radiologic structure, is correlated with hearing loss in ears with an enlarged vestibular aqueduct. Laryngoscope 120: 384–389.
- View Article
- Google Scholar
39. Albert S, Blons H, Jonard L, Feldmann D, Chauvin P, et al. (2006) SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations. Eur J Hum Genet 14: 773–779.
- View Article
- Google Scholar
40. Scott DA, Wang R, Kreman TM, Andrews M, McDonald JM, et al. (2000) Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum Mol Genet 9: 1709–1715.
- View Article
- Google Scholar
41. Taylor JP, Metcalfe RA, Watson PF, Weetman AP, Trembath RC (2002) Mutations of the PDS gene, encoding pendrin, are associated with protein mislocalization and loss of iodide efflux: implications for thyroid dysfunction in Pendred syndrome. J Clin Endocrinol Metab 87: 1778–1784.
- View Article
- Google Scholar
42. Choi BY, Stewart AK, Madeo AC, Pryor SP, Lenhard S, et al. (2009) Hypo-functional SLC26A4 variants associated with nonsyndromic hearing loss and enlargement of the vestibular aqueduct: genotype-phenotype correlation or coincidental polymorphisms? Hum Mutat 30: 599–608.
- View Article
- Google Scholar

[ref1] 1. Hilgert N, Smith RJ, Van Camp G (2009) Forty-six genes causing nonsyndromic hearing impairment: Which ones should be analyzed in DNA diagnostics? Mutat Res 681: 189–196.
View Article
Google Scholar

[2] View Article

[3] Google Scholar

[ref2] 2. Wu CC, Chen PJ, Chiu YH, Lu YC, Wu MC, et al. (2008) Prospective mutation screening of three common deafness genes in a large Taiwanese Cohort with idiopathic bilateral sensorineural hearing impairment reveals a difference in the results between families from hospitals and those from rehabilitation facilities. Audiol Neurootol 13: 172–181.
View Article
Google Scholar

[5] View Article

[6] Google Scholar

[ref3] 3. Everett LA, Morsli H, Wu DK, Green ED (1999) Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear. Proc Natl Acad Sci U S A 96: 9727–9732.
View Article
Google Scholar

[8] View Article

[9] Google Scholar

[ref4] 4. Royaux IE, Suzuki K, Mori A, Katoh R, Everett LA, et al. (2000) Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 141: 839–845.
View Article
Google Scholar

[11] View Article

[12] Google Scholar

[ref5] 5. Royaux IE, Karniski LP, Everett LA, Knepper MA, Green ED, et al. (2001) Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci U S A 98: 4221–4226.
View Article
Google Scholar

[14] View Article

[15] Google Scholar

[ref6] 6. Soleimani M, Greeley T, Petrovic S, Wang ZH, Amlal H, et al. (2001) Pendrin: an apical Cl(−)/OH(−)/HCO(3)(−) exchanger in the kidney cortex. Am J Physiol Renal Physiol 280: F356–364.
View Article
Google Scholar

[17] View Article

[18] Google Scholar

[ref7] 7. Shcheynikov N, Yang DK, Wang YX, Zeng WZ, Karniski LP, et al. (2008) The Slc26a4 transporter functions as an electroneutral Cl(−)/I(−)/HCO(3)(−) exchanger: role of Slc26a4 and Slc26a6 in I(−) and HCO(3)(−) secretion and in regulation of CFTR in the parotid duct. J Physiol 586: 3813–3824.
View Article
Google Scholar

[20] View Article

[21] Google Scholar

[ref8] 8. Nakao I, Kanaji S, Ohta S, Matsushita H, Arima K, et al. (2008) Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease. J Immunol 180: 6262–6269.
View Article
Google Scholar

[23] View Article

[24] Google Scholar

[ref9] 9. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, et al. (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17: 411–422.
View Article
Google Scholar

[26] View Article

[27] Google Scholar

[ref10] 10. Li XC, Everett LA, Lalwani AK, Desmukh D, Friedman TB, et al. (1998) A mutation in PDS causes non-syndromic recessive deafness. Nat Genet 18: 215–217.
View Article
Google Scholar

[29] View Article

[30] Google Scholar

[ref11] 11. Pryor SP, Madeo AC, Reynolds JC, Sarlis NJ, Arnos KS, et al. (2005) SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities. J Med Genet 42: 159–165.
View Article
Google Scholar

[32] View Article

[33] Google Scholar

[ref12] 12. Azaiez H, Yang T, Prasad S, Sorensen JL, Nishimura CJ, et al. (2007) Genotype-phenotype correlations for SLC26A4-related deafness. Hum Genet 122: 451–457.
View Article
Google Scholar

[35] View Article

[36] Google Scholar

[ref13] 13. Mori T, Westerberg BD, Atashband S, Kozak FK (2008) Natural history of hearing loss in children with enlarged vestibular aqueduct syndrome. J Otolaryngol Head Neck Surg 37: 112–118.
View Article
Google Scholar

[38] View Article

[39] Google Scholar

[ref14] 14. Everett LA, Belyantseva IA, Noben-Trauth K, Cantos R, Chen A, et al. (2001) Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet 10: 153–161.
View Article
Google Scholar

[41] View Article

[42] Google Scholar

[ref15] 15. Dror AA, Politi Y, Shahin H, Lenz DR, Dossena S, et al. (2010) Calcium oxalate stone formation in the inner ear as a result of an Slc26a4 mutation. J Biol Chem 28: 21724–21735.
View Article
Google Scholar

[44] View Article

[45] Google Scholar

[ref16] 16. Lu YC, Wu CC, Shen WS, Yang TH, Yeh TH, et al. (2011) Establishment of a knock-in mouse model with the SLC26A4 c.919–2A>G mutation and characterization of its pathology. PLoS One 6: e22150.
View Article
Google Scholar

[47] View Article

[48] Google Scholar

[ref17] 17. Choi BY, Kim HM, Ito T, Lee KY, Li XM, et al. (2011) Mouse model of enlarged vestibular aqueducts defines temporal requirement of Slc26a4 expression for hearing acquisition. J Clin Invest 121: 4516–4525.
View Article
Google Scholar

[50] View Article

[51] Google Scholar

[ref18] 18. Tsukamoto K, Suzuki H, Harada D, Namba A, Abe S, et al. (2003) Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese. Eur J Hum Genet 11: 916–922.
View Article
Google Scholar

[53] View Article

[54] Google Scholar

[ref19] 19. Park HJ, Lee SJ, Jin HS, Lee JO, Go SH, et al. (2005) Genetic basis of hearing loss associated with enlarged vestibular aqueducts in Koreans. Clin Genet 67: 160–165.
View Article
Google Scholar

[56] View Article

[57] Google Scholar

[ref20] 20. Wu CC, Yeh TH, Chen PJ, Hsu CJ (2005) Prevalent SLC26A4 mutations in patients with enlarged vestibular aqueduct and/or Mondini dysplasia: a unique spectrum of mutations in Taiwan, including a frequent founder mutation. Laryngoscope 115: 1060–1064.
View Article
Google Scholar

[59] View Article

[60] Google Scholar

[ref21] 21. Wang QJ, Zhao YL, Rao SQ, Guo YF, Yuan H, et al. (2007) A distinct spectrum of SLC26A4 mutations in patients with enlarged vestibular aqueduct in China. Clin Genet 72: 245–254.
View Article
Google Scholar

[62] View Article

[63] Google Scholar

[ref22] 22. Yuan Y, Guo W, Tang J, Zhang G, Wang G, et al. (2012) Molecular epidemiology and functional assessment of novel allelic variants of SLC26A4 in non-syndromic hearing loss patients with enlarged vestibular aqueduct in China. PLoS One 7: e49984.
View Article
Google Scholar

[65] View Article

[66] Google Scholar

[ref23] 23. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, et al. (2001) A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73: 56–65.
View Article
Google Scholar

[68] View Article

[69] Google Scholar

[ref24] 24. Su KY, Chien WL, Fu WM, Yu IS, Huang HP, et al. (2007) Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory. J Neurosci 27: 2513–2524.
View Article
Google Scholar

[71] View Article

[72] Google Scholar

[ref25] 25. Belyantseva IA, Adler HJ, Curi R, Frolenkov GI, Kachar B (2000) Expression and localization of prestin and the sugar transporter GLUT-5 during development of electromotility in cochlear outer hair cells. J Neurosci 20: RC116.
View Article
Google Scholar

[74] View Article

[75] Google Scholar

[ref26] 26. Wangemann P, Kim HM, Billings S, Nakaya K, Li X, et al. (2009) Developmental delays consistent with cochlear hypothyroidism contribute to failure to develop hearing in mice lacking Slc26a4/pendrin expression. Am J Physiol Renal Physiol 297: F1435–1447.
View Article
Google Scholar

[77] View Article

[78] Google Scholar

[ref27] 27. Wangemann P, Itza EM, Albrecht B, Wu T, Jabba SV, et al. (2004) Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med 2: 30.
View Article
Google Scholar

[80] View Article

[81] Google Scholar

[ref28] 28. Yang T, Gurrola JGII, Wu H, Chiu SM, Wangemann P, et al. (2009) Mutations of KCNJ10 together with mutations of SLC26A4 cause digenic nonsyndromic hearing loss associated with enlarged vestibular aqueduct syndrome. Am J Hum Genet 84: 651–657.
View Article
Google Scholar

[83] View Article

[84] Google Scholar

[ref29] 29. Ohlemiller KK, Gagnon PM (2007) Genetic dependence of cochlear cells and structures injured by noise. Hear Res 224: 34–50.
View Article
Google Scholar

[86] View Article

[87] Google Scholar

[ref30] 30. Sugiura M, Sato E, Nakashima T, Sugiura J, Furuhashi A, et al. (2005) Long-term follow-up in patients with Pendred syndrome: vestibular, auditory and other phenotypes. Eur Arch Otorhinolaryngol 262: 737–743.
View Article
Google Scholar

[89] View Article

[90] Google Scholar

[ref31] 31. Park HJ, Shaukat S, Liu XZ, Hahn SH, Naz S, et al. (2003) Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness. J Med Genet 40: 242–248.
View Article
Google Scholar

[92] View Article

[93] Google Scholar

[ref32] 32. Yoon JS, Park HJ, Yoo SY, Namkung W, Jo MJ, et al. (2008) Heterogeneity in the processing defect of SLC26A4 mutants. J Med Genet 45: 411–419.
View Article
Google Scholar

[95] View Article

[96] Google Scholar

[ref33] 33. Ishihara K, Okuyama S, Kumano S, Iida K, Hamana H, et al. (2010) Salicylate restores transport function and anion exchanger activity of missense pendrin mutations. Hear Res 270: 110–118.
View Article
Google Scholar

[98] View Article

[99] Google Scholar

[ref34] 34. Barbaric I, Miller G, Dear TN (2007) Appearances can be deceiving: phenotypes of knockout mice. Brief Funct Genomic Proteomic 6: 91–103.
View Article
Google Scholar

[101] View Article

[102] Google Scholar

[ref35] 35. Pearson H (2002) Surviving a knockout blow. Nature 415: 8–9.
View Article
Google Scholar

[104] View Article

[105] Google Scholar

[ref36] 36. Singh R, Wangemann P (2008) Free radical stress-mediated loss of Kcnj10 protein expression in stria vascularis contributes to deafness in Pendred syndrome mouse model. Am J Physiol Renal Physiol 294: F139–148.
View Article
Google Scholar

[107] View Article

[108] Google Scholar

[ref37] 37. Berezin C, Glaser F, Rosenberg J, Paz I, Pupko T, et al. (2004) ConSeq: the identification of functionally and structurally important residues in protein sequences. Bioinformatics 20: 1322–1324.
View Article
Google Scholar

[110] View Article

[111] Google Scholar

[ref38] 38. King KA, Choi BY, Zalewski C, Madeo AC, Manichaikul A, et al. (2010) SLC26A4 genotype, but not cochlear radiologic structure, is correlated with hearing loss in ears with an enlarged vestibular aqueduct. Laryngoscope 120: 384–389.
View Article
Google Scholar

[113] View Article

[114] Google Scholar

[ref39] 39. Albert S, Blons H, Jonard L, Feldmann D, Chauvin P, et al. (2006) SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations. Eur J Hum Genet 14: 773–779.
View Article
Google Scholar

[116] View Article

[117] Google Scholar

[ref40] 40. Scott DA, Wang R, Kreman TM, Andrews M, McDonald JM, et al. (2000) Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum Mol Genet 9: 1709–1715.
View Article
Google Scholar

[119] View Article

[120] Google Scholar

[ref41] 41. Taylor JP, Metcalfe RA, Watson PF, Weetman AP, Trembath RC (2002) Mutations of the PDS gene, encoding pendrin, are associated with protein mislocalization and loss of iodide efflux: implications for thyroid dysfunction in Pendred syndrome. J Clin Endocrinol Metab 87: 1778–1784.
View Article
Google Scholar

[122] View Article

[123] Google Scholar

[ref42] 42. Choi BY, Stewart AK, Madeo AC, Pryor SP, Lenhard S, et al. (2009) Hypo-functional SLC26A4 variants associated with nonsyndromic hearing loss and enlargement of the vestibular aqueduct: genotype-phenotype correlation or coincidental polymorphisms? Hum Mutat 30: 599–608.
View Article
Google Scholar

[125] View Article

[126] Google Scholar

Figures

Abstract

Introduction

Materials and Methods

Construction of Slc26a4tm2Dontuh/tm2Dontuh Knock-in Mice

Audiological and Vestibular Evaluations

Inner Ear Morphology Studies

Expression of Pendrin

Real-time PCR

Western Blot Analysis

Noise Exposure Experiments

Thyroid and Renal Serum Biochemistry

Results

Audiological and Vestibular Phenotypes

Cochlear Morphology

Vestibular Morphology

Immunolocalization and Expression of Pendrin

Kcnj10 Expression

Noise Exposure Experiments

Thyroid and Renal Profiles

Discussion

Supporting Information

Figure S1.

Table S1.

Table S2.

Acknowledgments

Author Contributions

References

Construction of Slc26a4^{tm2Dontuh/tm2Dontuh} Knock-in Mice